Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.03.2019 | Case report

Sorafenib

Acquired perforating dermatosis, reactive perforating collagenosis type: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 65-year-old man developed reactive perforating collagenosis type acquired perforating dermatosis during treatment with sorafenib for hepatocellular carcinoma. …
Literatur
Zurück zum Zitat Lederhandler M, et al. Unusual eruption in association with sorafenib: A case of acquired perforating dermatosis, reactive perforating collagenosis type. Dermatology Online Journal 24: 11, No. 12, Dec 2018. Available from: URL: https://escholarship.org/uc/item/8b40k5kg - USA Lederhandler M, et al. Unusual eruption in association with sorafenib: A case of acquired perforating dermatosis, reactive perforating collagenosis type. Dermatology Online Journal 24: 11, No. 12, Dec 2018. Available from: URL: https://​escholarship.​org/​uc/​item/​8b40k5kg - USA
Metadaten
Titel
Sorafenib
Acquired perforating dermatosis, reactive perforating collagenosis type: case report
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-59410-x

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe